CONMED
CNMD
234 hedge funds and large institutions have $2.8B invested in CONMED in 2019 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 89 increasing their positions, 72 reducing their positions, and 27 closing their positions.
24% more repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 72
15% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 27
12% more capital invested
Capital invested by funds: $2.5B → $2.8B (+$301M)
2% more funds holding
Funds holding: 230 → 234 (+4)
0.54% less ownership
Funds ownership: 103.6% → 103.06% (-0.54%)
13% less call options, than puts
Call options by funds: $5.33M | Put options by funds: $6.13M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCI
Columbus Circle Investors
|
+$24M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$22.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.8M |
| 4 |
BlackRock
New York
|
+$18M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
+$13.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$62.9M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$13.6M |
| 3 |
Fisher Asset Management
Camas,
Washington
|
-$13.4M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$13.3M |
| 5 |
Goldman Sachs
New York
|
-$11.9M |
CNMD Hedge Fund Activity: Q3 2019 in Review
234 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q3 2019, worth a combined $2.8B — up 12% from $2.5B a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new CNMD positions and 27 closed out — a net gain of 4 holders — while 89 added to existing stakes and 72 trimmed.
The largest buyer was Columbus Circle Investors, opening a new position worth an estimated $24M. The largest seller was Point72 Asset Management, cutting an estimated $62.9M.
- 234 institutional investors held CONMED (CNMD) as of Q3 2019, up from 230 in Q2 2019.
- Funds reported $2.8B of CONMED stock for Q3 2019, up 12% quarter-over-quarter.
- 31 funds opened new CONMED positions in Q3 2019 and 27 closed out, a net change of +4 holders.
- The largest CONMED buyer in Q3 2019 was Columbus Circle Investors, an estimated $24M added.
- The largest CONMED seller in Q3 2019 was Point72 Asset Management, an estimated $62.9M sold.
Based on aggregated 13F filings for Q3 2019.